Flume Health Inc.

Flume Health Inc. delivers a specialized data integration platform for healthcare, enhancing interoperability among payers, TPAs, and vendors through advanced technology solutions. Founded in 2017, Flume Health Inc. is headquartered in New York, US.

The company focuses on integrating healthcare data through its innovative platform. Cédric Kovacs-Johnson serves as both the founder and CEO, driving the vision of the company. In January 2022, Flume Health raised USD 29. 95 mn in a Series A funding round led by Optum Ventures, with participation from Cigna Ventures and several other investors.

This funding round brought the total amount raised by Flume to USD 29. 95 mn, valuing the company at USD 107. 18 mn. Flume Health, Inc.

offers a comprehensive data integration platform tailored specifically for the healthcare sector, focusing on the interoperability needs of health payers, third-party administrators (TPAs), and solution vendors. The core product utilizes advanced AI technology to facilitate seamless data exchanges, enabling organizations to connect with multiple partners and manage vast amounts of healthcare data securely and efficiently. The platform is designed to tackle significant challenges in the industry, such as data fragmentation and regulatory compliance, ensuring that clients can optimize member experiences and streamline operations. Flume’s offerings are deployed across various geographical markets, including the United States and Canada, serving an extensive client base comprised of payers, health plans, and vendors who require reliable and flexible data integration solutions.

Flume Health generates revenue primarily through subscriptions for its data integration services, which provide clients access to its advanced platform. These subscription models often involve tiered pricing structures based on the level of service required and the scale of data managed. For instance, health payers and TPAs may enter into agreements that emphasize multi-directional data flows and customized connectivity solutions, fostering collaborative partnerships that enhance operational efficiency. The revenue structure benefits from diversified service offerings, as clients leverage Flume’s capabilities to adapt to evolving regulatory landscapes and increase their data management efficiencies.

Additionally, the company’s commitment to ensuring security and compliance is a key selling point that bolsters its appeal within the competitive healthcare data market. Flume Health Inc. aims to enhance its product offerings with new features designed to improve data integration processes, although specific release dates have not been disclosed. The company is also planning to expand into additional markets, focusing on further penetration in North America and potential entry into European markets by 2024.

The funds raised in January 2022 through the Series A funding round, amounting to USD 29. 95 mn, will be utilized to support these product developments and market expansion efforts.